相似文献
1
Prognosis in familial non-polyposis colorectal cancer.
Gut. 1991 May;32(5):513-6. doi: 10.1136/gut.32.5.513.
2
Histologic characteristics and outcome of familial non-polyposis colorectal carcinoma.
Scand J Gastroenterol. 1991 Apr;26(4):419-24. doi: 10.3109/00365529108996504.
3
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Oncologist. 1996;1(5):326-330.
4
Prolonged survival in hereditary nonpolyposis colorectal cancer.
Oncol Rep. 1999 Mar-Apr;6(2):321-4. doi: 10.3892/or.6.2.321.
5
How prevalent is cancer family syndrome?
Gut. 1991 May;32(5):509-12. doi: 10.1136/gut.32.5.509.
6
Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):209-12.
7
Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
Colorectal Dis. 2013 Jul;15(7):816-23. doi: 10.1111/codi.12150.
8
Is the phenotype mixed or mistaken? Hereditary nonpolyposis colorectal cancer and hyperplastic polyposis syndrome.
Dis Colon Rectum. 2009 Dec;52(12):1949-55. doi: 10.1007/DCR.0b013e3181b5450c.
9
Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study.
BMJ. 2005 Nov 5;331(7524):1047. doi: 10.1136/bmj.38606.794560.EB. Epub 2005 Oct 21.
10
Screening of patients with a positive family history of colorectal cancer.
Gastrointest Endosc Clin N Am. 1997 Jan;7(1):65-79.
引用本文的文献
1
Prognosis in DNA mismatch repair deficient colorectal cancer: are all MSI tumours equivalent?
Fam Cancer. 2004;3(2):85-91. doi: 10.1023/B:FAME.0000039915.94550.cc.
2
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.
Am J Pathol. 1999 Jun;154(6):1805-13. doi: 10.1016/S0002-9440(10)65436-3.
本文引用的文献
1
Outcome in colorectal carcinoma: seven-year study of a population.
Br Med J. 1980 Feb 16;280(6212):431-5. doi: 10.1136/bmj.280.6212.431.
2
Natural history of hereditary cancer of the breast and colon.
Cancer. 1982 Jul 15;50(2):360-3. doi: 10.1002/1097-0142(19820715)50:2<360::aid-cncr2820500233>3.0.co;2-4.
3
The analysis of mortality by the subject-years method.
Biometrics. 1983 Mar;39(1):173-84.
4
Factors associated with speed of diagnosis, referral, and treatment in colorectal cancer.
J Epidemiol Community Health. 1984 Jun;38(2):122-6. doi: 10.1136/jech.38.2.122.
5
Factors affecting compliance with screening for colorectal cancer.
Community Med. 1984 Feb;6(1):12-9.
6
[Comparison of tumor incidence in 251 first-degree relatives of 50 patients with colorectal carcinoma with those of the Basel population].
Schweiz Med Wochenschr. 1985 Jul 20;115(29):1005-6.
7
Familial heterogeneity of colon cancer risk.
Cancer. 1986 May 15;57(10):2089-96. doi: 10.1002/1097-0142(19860515)57:10<2089::aid-cncr2820571034>3.0.co;2-j.
8
Clinical features of colorectal carcinoma in cancer family syndrome.
Dis Colon Rectum. 1986 Mar;29(3):160-4. doi: 10.1007/BF02555012.
9
A comparison of positive family history definitions for defining risk of future disease.
J Chronic Dis. 1986;39(10):809-21. doi: 10.1016/0021-9681(86)90083-4.
10
Tumour site: a prognostic factor in colorectal cancer? A multivariate analysis.
Scand J Gastroenterol. 1987 Jan;22(1):124-8. doi: 10.3109/00365528708991868.
Zotero 插件